-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
IQVIA at DIA 2022: DAY 3 Recap
Jun 22, 2022
We just wrapped up another exciting and packed day of DIA 2022, tearing down informational boundaries and working together to positively impact patient lives around the world. The COVID-19 global pandemic has certainly shed light on quite a few ways industry stakeholders need to strengthen collaborations to ensure drug development meets the needs of patients around the globe.
At a time like no other in our history, we experienced a renewed focus from the collective industry to embrace innovation and better address gaps in diversity and inclusion in clinical trials for underrepresented communities. Several of today’s discussions specifically focused on strategic ways to address barriers to participation in trials:
- Vice President of the Analytics Center of Excellence at IQVIA Lucas Glass participated in the “Approaches to Addressing Diversity and Inclusion in Clinical Research”https://sched.co/vWRP session, where he joined a panel of experts to help attendees identify specific barriers to sufficient patient representation in clinical trials and to share his recommendations on how sponsors can leverage artificial intelligence (AI) and machine learning (ML) to better inform trial site selection and optimize enrollment among diverse patient populations. By using principles of fairness in ML, AI can help to improve trial participation and proportionate representation.
- During the “Leveraging Real-World Evidence (RWE) to Address Diversity Gaps in Randomized Clinical Trials: Regulatory, Clinical and Other Considerations” DIAmond session, IQVIA’s Chief Scientific Officer Nancy Dreyer chaired a panel discussion among fellow research and development experts to highlight how the lack of diversity in trials can impact the reliability of evidence-based care algorithms and to provide attendees with insight how RWE can supplement randomized clinical trials to fill evidence gaps and better address diversity. Additionally, as RWE is a hot topic for discussion at this year’s DIA, IQVIA also led an Innovation Theater presentation today on “RWE to Enhance Clinical Development”. IQVIA’s Medical Affairs Category Lead for Real World Evidence Barbara Isquith Arone joined Paul Petraro, global head of the Real World Evidence Analytic Center of Excellence at Boehringer Ingelheim Pharmaceuticals, to showcase the new uses of RWE, including:
- Supporting trial design.
- Providing context for interventional studies.
- Helping to create practical approaches to the long term monitoring of cell and gene therapies.
Barbara shared how the growing acceptance of RWE in product development is moving quickly and when sponsors may want to consider its use to optimize their development processes.
So far, DIA 2022 has been an amazing experience for the IQVIA team, filled with many invaluable learnings and important dialogue with fellow attendees. Today’s thoughtful discussions emphasize how enhanced collaboration and transparency with each other in the industry can help ensure we all make a tangible difference in improving patients’ lives together.
As always, for DIA 2022 attendees and others interested in connecting with our experts to learn more about our innovative solutions, come by our IQVIA booth (#1300) and Q2 Solutions booth (#1209) before the meeting ends tomorrow. We’d love to connect with you! While you’re there, feel free to experience one or more of the demo stations highlighting our solutions in decentralized trials, patient recruitment, drug discovery and development, electronic clinical outcome assessment (eCOA) and digital trial management and data analytics.
Cheers to another rewarding day at DIA!